Dr. Terrence Blaschke is a Senior Program Officer in Clinical Pharmacology at the Bill and Melinda Gates Foundation, and Professor Emeritus of Medicine and Clinical Pharmacology at Stanford University School of Medicine. His research examines the clinical pharmacology of drugs used with HIV-infected patients. His research focuses on the quality of antiretroviral drugs and the ability of patients’ to access drugs. In addition, Dr. Blaschke collaborates with the AMPATH program in Eldoret, Kenya, a comprehensive initiative to build the public sector’s HIV prevention and treatment capacity in urban and rural settings. He is on the Organizing Committee for a workshop on Clinical Pharmacology in HIV therapy. He holds an M.D. from Columbia University.